authorized surgical app for the Apple Vision Pro

Stryker's SportSuite Vision Software received FDA approval for use in specific hip arthroscopy procedures, creating a new device class (888.1150, Class 2). The approval took 318 days and does not tie the software to Apple's Vision Pro hardware. The classification covers a broader range of orthopedic surgeries, potentially easing future submissions for similar devices. Stryker did not receive a predetermined change control plan, which may impact future modifications.

Intuitive Surgical (ISRG) and Stryker (SYK) both reported strong Q2 2026 earnings, with ISRG highlighting 85% recurring revenue and SYK showing 9.4% revenue growth. ISRG's da Vinci systems and SYK's MedSurg and Neurotechnology segments drove performance. ISRG's CEO noted portfolio strength, while SYK's CEO cited regained momentum. Analysts favor ISRG for its compounding moat and recurring revenue model, with 25 EPS revisions in 30 days.

Dr. Chad Mather III at Duke Health performed hip surgery using Apple Vision Pro with Stryker’s FDA-authorized SportSuite Vision app, displaying critical data in the surgeon’s field of view. The FDA granted De Novo authorization for this use on July 17, 2026, classifying it as a Class II orthopedic device. This marks the first real-world clinical use of such technology, announced on September 1, 2026.

Stryker's SportSuite Vision app for Apple Vision Pro was used in a hip surgery at Duke Health, marking its first real-world application. The FDA authorized the software on July 17. The app provided the surgeon with orthopedic tools and imaging during the procedure.

Stryker (SYK) announced it will acquire ZuriMED, developer of the FiberLocker System for rotator cuff augmentation, to expand its shoulder care portfolio. The deal aims to strengthen Stryker's offerings and support long-term growth in the sports medicine market. SYK shares fell 2.1% following the news, with a year-to-date decline of 7.8%. The global rotator cuff repair market is projected to grow at a 7.6% CAGR through 2033, according to Grand View Research.

Stryker (NYSE:SYK) completed the first surgery using its SportSuite Vision app on Apple Vision Pro at Duke Health. The FDA authorized the app for intraoperative use on July 17. The technology displays arthroscopic video and imaging in a spatial computing environment, aiding surgeons during hip arthroscopy procedures. Stryker manufactures medical technology products in various segments.